Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / 2020 - Page 28

Year: 2020

Experimental COVID-19 vaccine prevented severe disease in mice
Biotechnology | COVID-19 | Vaccine

Experimental COVID-19 vaccine prevented severe disease in mice

On Aug. 19, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…

Read More Experimental COVID-19 vaccine prevented severe disease in miceContinue

Johnson & Johnson acquired Momenta Pharmaceuticals for $65 billion
Life Science History

Johnson & Johnson acquired Momenta Pharmaceuticals for $65 billion

On Aug. 19, 2020, Johnson & Johnson announced an agreement to acquire Momenta Pharmaceuticals, a company that discovers…

Read More Johnson & Johnson acquired Momenta Pharmaceuticals for $65 billionContinue

UT Southwestern announced open enrollment for at-home COLCORONA clinical trial
Biotechnology | COVID-19 | Infectious Disease

UT Southwestern announced open enrollment for at-home COLCORONA clinical trial

On Aug. 19, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced what is expected…

Read More UT Southwestern announced open enrollment for at-home COLCORONA clinical trialContinue

Spike protein of the new corona virus is more flexible than expected
Non-Profit Research | Vaccine

Spike protein of the new corona virus is more flexible than expected

On Aug. 18, 2020, scientists from the Max Planck Institute for Biophysics, the Paul Ehrlich Institute, the European…

Read More Spike protein of the new corona virus is more flexible than expectedContinue

HKUMed researchers discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune response
COVID-19 | Life Science History

HKUMed researchers discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune response

On Aug. 18, 2020, researchers from HKU-Pasteur Research Pole at the School of Public Health, LKS Faculty of…

Read More HKUMed researchers discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune responseContinue

Regeneron and Roche collaborate to significantly increase global supply of REGN-COV2 investigational antibody cocktail for COVID-19
COVID-19 | Life Science History

Regeneron and Roche collaborate to significantly increase global supply of REGN-COV2 investigational antibody cocktail for COVID-19

On Aug. 18, 2020, Regeneron and Roche announced that they had joined forces in the fight against COVID-19…

Read More Regeneron and Roche collaborate to significantly increase global supply of REGN-COV2 investigational antibody cocktail for COVID-19Continue

NIH delivered $43 million to support convalescent plasma clinical trial
COVID-19 | Life Science History

NIH delivered $43 million to support convalescent plasma clinical trial

On Aug. 18, 2020, the National Institutes of Health awarded Albert Einstein College of Medicine and Montefiore a…

Read More NIH delivered $43 million to support convalescent plasma clinical trialContinue

Vanda Pharma’s interim analysis from ODYSSEY study showed tradipitant may accelerate clinical improvement in patients with COVID-19 pneumonia
COVID-19 | Life Science History

Vanda Pharma’s interim analysis from ODYSSEY study showed tradipitant may accelerate clinical improvement in patients with COVID-19 pneumonia

On Aug. 18, 2020, Vanda Pharma reported that interim analysis showed tradipitant may accelerate clinical improvement in SARS-CoV-2…

Read More Vanda Pharma’s interim analysis from ODYSSEY study showed tradipitant may accelerate clinical improvement in patients with COVID-19 pneumoniaContinue

Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal spray
Biotechnology | COVID-19

Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal spray

On Aug. 17, 2020, Atossa Therapeutics announced that it had enrolled and dosed the first cohort of healthy…

Read More Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal sprayContinue

Costa Rica announced horse antibodies for trials as an inexpensive COVID-19 therapy
Biotechnology | Therapeutics

Costa Rica announced horse antibodies for trials as an inexpensive COVID-19 therapy

On Aug. 17, 2020, Scientisfic American reported that Costa Rican scientists at the Clodomiro Picado Institute have inoculated…

Read More Costa Rica announced horse antibodies for trials as an inexpensive COVID-19 therapyContinue

USDA confirmed SARS-CoV-2 in mink in Utah
COVID-19 | USDA | Veterinary

USDA confirmed SARS-CoV-2 in mink in Utah

On Aug. 17, 2020, the USDA National Veterinary Services Laboratories (NVSL) announced the first confirmed cases of SARS-CoV-2…

Read More USDA confirmed SARS-CoV-2 in mink in UtahContinue

FDA approved teatment for rare disease affecting optic nerves, spinal cord
Biotechnology | FDA | Neurology

FDA approved teatment for rare disease affecting optic nerves, spinal cord

On Aug. 17, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Enspryng (satralizumab-mwge) for the treatment…

Read More FDA approved teatment for rare disease affecting optic nerves, spinal cordContinue

PerkinElmer launched Modular and Scalable explorer workstations for high-throughput COVID-19 detection
COVID-19 | Medical Device

PerkinElmer launched Modular and Scalable explorer workstations for high-throughput COVID-19 detection

On Aug. 17, 2020, PerkinElmer announced the launch of a series of explorerル workstations for SARS-CoV-2 testing capable…

Read More PerkinElmer launched Modular and Scalable explorer workstations for high-throughput COVID-19 detectionContinue

Novavax initiated efficacy trial of COVID-19 vaccine in South Africa
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax initiated efficacy trial of COVID-19 vaccine in South Africa

On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…

Read More Novavax initiated efficacy trial of COVID-19 vaccine in South AfricaContinue

Sanofi acquired Principia Biopharma for $3.68 billion
Biotechnology | Pharmaceutical

Sanofi acquired Principia Biopharma for $3.68 billion

On Aug. 17, 2020, Sanofi and Principia Biopharma announced a definitive agreement under which Sanofi will acquire all…

Read More Sanofi acquired Principia Biopharma for $3.68 billionContinue

XBiotech announced COVID-19 candidate therapy
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

XBiotech announced COVID-19 candidate therapy

On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…

Read More XBiotech announced COVID-19 candidate therapyContinue

FDA issued Emergency Use Authorization to Yale School of Public Health for SalivaDirect method of saliva sample processing
COVID-19 | FDA | Life Science History

FDA issued Emergency Use Authorization to Yale School of Public Health for SalivaDirect method of saliva sample processing

On Aug. 15, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…

Read More FDA issued Emergency Use Authorization to Yale School of Public Health for SalivaDirect method of saliva sample processingContinue

Quick and affordable saliva-based COVID-19 test developed by Yale scientists received FDA Emergency Use Authorization
FDA | Life Science History

Quick and affordable saliva-based COVID-19 test developed by Yale scientists received FDA Emergency Use Authorization

On Aug. 15, 2020, a saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public…

Read More Quick and affordable saliva-based COVID-19 test developed by Yale scientists received FDA Emergency Use AuthorizationContinue

NIH-supported research demonstrates how genetic variations cause eczema
Biotechnology | Disease | Non-Profit Research | Therapeutics

NIH-supported research demonstrates how genetic variations cause eczema

On Aug. 14, 2020, research supported by the National Institutes of Health delineated how two relatively common variations…

Read More NIH-supported research demonstrates how genetic variations cause eczemaContinue

Vaccine refusal and measles outbreaks increased in the U.S.
Biotechnology | Diagnostics | Infectious Disease | Measles | Vaccine

Vaccine refusal and measles outbreaks increased in the U.S.

On Aug. 14, 2020, in the U.S., despite high rates of coverage (>90%) at the national level for…

Read More Vaccine refusal and measles outbreaks increased in the U.S.Continue

AstraZeneca concluded agreement with the EC for supply of up to 400 million doses of AZD1222 COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

AstraZeneca concluded agreement with the EC for supply of up to 400 million doses of AZD1222 COVID-19 vaccine

On Aug. 14, 2020, AstraZeneca concluded an agreement with the European Commission (EC) to supply up to 400…

Read More AstraZeneca concluded agreement with the EC for supply of up to 400 million doses of AZD1222 COVID-19 vaccineContinue

Medigen Vaccines announced positive results of preclinical data for vaccine candidate against COVID-19
Biotechnology | COVID-19 | Therapeutics | Vaccine

Medigen Vaccines announced positive results of preclinical data for vaccine candidate against COVID-19

On Aug. 14, 2020, Medigen Vaccine Biologics (MBV) published preclinical results of their COVID-19 vaccine candidate in BioRxiv,…

Read More Medigen Vaccines announced positive results of preclinical data for vaccine candidate against COVID-19Continue

Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate

On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…

Read More Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidateContinue

Mapping tool highlights NIH-funded small business successes
Life Science History | NIH

Mapping tool highlights NIH-funded small business successes

On Aug. 13, 2020, the NIH announced a new interactive mapping tool that showcases just some of the…

Read More Mapping tool highlights NIH-funded small business successesContinue

2 in 5 schools around the world lacked basic handwashing facilities prior to COVID-19 pandemic
COVID-19 | WHO

2 in 5 schools around the world lacked basic handwashing facilities prior to COVID-19 pandemic

On Aug. 13, 2020, data from the WHO/UNICEF Joint Monitoring Programme (JMP) revealed that 43 per cent of…

Read More 2 in 5 schools around the world lacked basic handwashing facilities prior to COVID-19 pandemicContinue

ADHD risk may be linked to inflammation during pregnancy
Biotechnology | Diagnostics | Disease | Neurology | Therapeutics | Women's Health

ADHD risk may be linked to inflammation during pregnancy

On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…

Read More ADHD risk may be linked to inflammation during pregnancyContinue

Philips launched Rapid Equipment Deployment Kit to COVID-19 response
COVID-19 | Life Science History

Philips launched Rapid Equipment Deployment Kit to COVID-19 response

On Aug. 13, 2020, Royal Philips introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses,…

Read More Philips launched Rapid Equipment Deployment Kit to COVID-19 responseContinue

Dynavax announced grant to scale up CpG 1018 adjuvant capacity to support global COVID-19 response
COVID-19 | Life Science History

Dynavax announced grant to scale up CpG 1018 adjuvant capacity to support global COVID-19 response

On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…

Read More Dynavax announced grant to scale up CpG 1018 adjuvant capacity to support global COVID-19 responseContinue

Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate

On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…

Read More Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidateContinue

Heat Biologics’ COVID-19 vaccine demonstrated robust T cell driven immune response to SARS-CoV-2 in preclinical studies
COVID-19 | Life Science History | Vaccine

Heat Biologics’ COVID-19 vaccine demonstrated robust T cell driven immune response to SARS-CoV-2 in preclinical studies

On Aug. 13, 2020, Heat Biologics reported preclinical data for Heat’s gp96-based COVID-19. The data, generated at the…

Read More Heat Biologics’ COVID-19 vaccine demonstrated robust T cell driven immune response to SARS-CoV-2 in preclinical studiesContinue

Page navigation

Previous PagePrevious 1 … 26 27 28 29 30 … 76 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search